Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid
Author:
Open Access
- 1 January 2011
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 17 (1) , 111-7
Abstract
To investigate the effect of transgenic expression of kallistatin (Kal) on carbon tetrachloride (CCl(4))-induced liver injury by intramuscular (im) electrotransfer of a Kal-encoding plasmid formulated with poly-L-glutamate (PLG). The pKal plasmid encoding Kal gene was formulated with PLG and electrotransferred into mice skeletal muscle before the administration of CCl4. The expression level of Kal was measured. The serum biomarker levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), malonyldialdehyde (MDA), and tumor necrosis factor (TNF)-α were monitored. The extent of CCl4-induced liver injury was analyzed histopathologically. The transgene of Kal was sufficiently expressed after an im injection of plasmid formulated with PLG followed by electroporation. In the Kal gene-transferred mice, protection against CCl4-induced liver injury was reflected by significantly decreased serum ALT, AST, MDA and TNF-α levels compared to those in control mice (P<0.01 to 0.05 in a dose-dependent manner). Histological observations also revealed that hepatocyte necrosis, hemorrhage, vacuolar change and hydropic degeneration were apparent in mice after CCl4 administration. In contrast, the damage was markedly attenuated in the Kal gene-transferred mice. The expression of hepatic fibrogenesis marker transforming growth factor-β1 was also reduced in the pKal transferred mice. Intramuscular electrotransfer of plasmid pKal which was formulated with PLG significantly alleviated the CCl4-induced oxidative stress and inflammatory response, and reduced the liver damage in a mouse model.Keywords
This publication has 23 references indexed in Scilit:
- Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approachDermatologic Therapy, 2010
- Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in MicePLOS ONE, 2010
- Real time electroporation control for accurate and safe in vivo non-viral gene therapyBioelectrochemistry, 2007
- Novel Role of Kallistatin in Protection Against Myocardial Ischemia–Reperfusion Injury by Preventing Apoptosis and InflammationHuman Gene Therapy, 2006
- Cytoglobin Overexpression Protects against Damage-Induced FibrosisMolecular Therapy, 2006
- Prophylactic adenovirus‐mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammationArthritis & Rheumatism, 2005
- Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applicationsThe Journal of Gene Medicine, 2004
- Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporationGene Therapy, 2002
- Safer and Virus-Free?Science, 2001
- High-efficiency gene transfer into skeletal muscle mediated by electric pulsesProceedings of the National Academy of Sciences, 1999